We are live on ! Find out more
Goldman Sachs

Goldman Sachs Portfolio holdings

AUM $871B
1-Year Est. Return 31.28%
 

Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.

This Fund
S&P 500
This Quarter Est. Return
+8.54%
1 Year Est. Return
+31.28%
3 Year Est. Return
+94.73%
5 Year Est. Return
+114.04%
10 Year Est. Return
+476.55%
AUM
$446B
AUM Growth
+$49.9B
Cap. Flow
+$20.1B
Cap. Flow %
4.51%
Top 10 Hldgs %
17.27%
Holding
6,869
New
821
Increased
2,556
Reduced
2,333
Closed
700

Sector Composition

Rank Sector Weight
1 Technology 14.59%
2 Consumer Discretionary 9.73%
3 Financials 8.55%
4 Healthcare 8.03%
5 Communication Services 6.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSAC
5726
DELISTED
Medicus Sciences Acquisition Corp. Class A Ordinary Share
MSAC
$163K ﹤0.01%
+16,918
New +$165K
FENG
5727
Phoenix New Media
FENG
$17.7M
$162K ﹤0.01%
17,442
+8,453
+94% +$84K
JOF
5728
Japan Smaller Capitalization Fund
JOF
$322M
$162K ﹤0.01%
+17,957
New +$165K
NCV
5729
Virtus Convertible & Income Fund
NCV
$378M
$162K ﹤0.01%
+6,601
New +$154K
NCZ
5730
Virtus Convertible & Income Fund II
NCZ
$294M
$162K ﹤0.01%
+7,562
New +$155K
SCOAW
5731
DELISTED
ScION Tech Growth I Warrant
SCOAW
$162K ﹤0.01%
154,726
AAQC.WS
5732
DELISTED
Accelerate Acquisition Corp Warrants
AAQC.WS
$162K ﹤0.01%
+131,582
New +$133K
BSM icon
5733
Black Stone Minerals
BSM
$3.18B
$161K ﹤0.01%
+15,010
New +$151K
FOCL
5734
EDAP TMS S.A.
FOCL
$229M
$161K ﹤0.01%
22,755
+1,630
+8% +$11.8K
APTX
5735
DELISTED
Aptinyx Inc. Common Stock
APTX
$161K ﹤0.01%
56,728
+16,832
+42% +$47K
ACET icon
5736
Adicet Bio
ACET
$85.2M
$160K ﹤0.01%
973
-1,887
-66% -$384K
BCSF icon
5737
Bain Capital Specialty
BCSF
$806M
$160K ﹤0.01%
+10,469
New +$165K
DNP icon
5738
DNP Select Income Fund
DNP
$4.05B
$160K ﹤0.01%
+15,335
New +$158K
NVGS icon
5739
Navigator Holdings
NVGS
$1.38B
$159K ﹤0.01%
14,479
-2,872
-17% -$30.3K
RMGC
5740
DELISTED
RMG Acquisition Corp. III Class A Ordinary Shares
RMGC
$159K ﹤0.01%
+16,356
New +$161K
ETACU
5741
DELISTED
E.Merge Technology Acquisition Corp. Unit
ETACU
$158K ﹤0.01%
15,700
CENHW
5742
DELISTED
Centricus Acquisition Corp. Warrant
CENHW
$158K ﹤0.01%
+113,079
New +$120K
GGAL icon
5743
Galicia Financial Group
GGAL
$7.99B
$157K ﹤0.01%
18,221
-1,357
-7% -$11.4K
IZEA icon
5744
IZEA Worldwide
IZEA
$60.6M
$157K ﹤0.01%
+15,440
New +$203K
VERA icon
5745
Vera Therapeutics
VERA
$2.3B
$156K ﹤0.01%
+11,747
New +$183K
GMDA
5746
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$155K ﹤0.01%
24,205
-7,313
-23% -$50.4K
STSA
5747
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$155K ﹤0.01%
21,930
+4,721
+27% +$25.5K
INFI
5748
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$154K ﹤0.01%
51,633
-45,092
-47% -$143K
JAKK icon
5749
Jakks Pacific
JAKK
$301M
$153K ﹤0.01%
13,948
+121
+0.9% +$1.11K
PAYS icon
5750
Paysign
PAYS
$501M
$153K ﹤0.01%
48,085
+9,254
+24% +$33.2K

Similar funds

Goldman Sachs's Q2 2021 Portfolio in Review

As of Q2 2021, Goldman Sachs held 6,869 positions worth $446B, up 13% from $396B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Goldman Sachs deployed $20.1B of net new capital in Q2 2021, opening 821 new positions and adding to 2,556 existing holdings. Its largest new stake was Privia Health: 30,513,629 shares worth $1.35B.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $960M trimmed.

  • Goldman Sachs's largest Q2 2021 buy was Privia Health: 30,513,629 shares worth $1.35B.
  • Goldman Sachs added most to Alibaba in Q2 2021, an estimated $1.31B increase.
  • Goldman Sachs's biggest Q2 2021 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $960M.
  • Goldman Sachs fully exited Pluralsight, Inc. Class A Common Stock in Q2 2021, selling an estimated $128M.
  • Goldman Sachs's ten largest holdings make up 17% of its $446B portfolio in Q2 2021.
  • Goldman Sachs opened 821 new positions and closed 700 in Q2 2021.
  • Goldman Sachs's portfolio value rose 13% quarter-over-quarter to $446B.

Based on Goldman Sachs's 13F filing for Q2 2021, filed 13 Aug 2021.